Infectious disease specialist Dr. Aileen Marty talks about Pfizer and omicron preliminary studies

Bob Sirott

FILE – The Pfizer logo is displayed at the company’s headquarters in New York, on Feb. 5, 2021. In a statement on Tuesday, Nov. 16, 2021, drugmaker Pfizer Inc. said it has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental coronavirus pill, in a move that could make its treatment available to more than half of the world’s population. (AP Photo/Mark Lennihan, File)

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joined Bob Sirott to talk about the latest health news. Dr.Marty talks about Pfizer’s effectiveness against omicron and discusses antibody drugs.

Copyright 2022 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

COVID-19 risk as determined by nonprofit Covid Act Now.

Coronavirus Resources from the CDC

Bob Sirott
Weekdays 6-10am BobSirott

Bob Sirott's acclaimed broadcasting career has spanned nearly five decades and has included stints at WMAQ, WBBM-FM, WLS, WGN and various television stations. (Click for more.)

Popular